BRPI0815130A2 - composição, e, método para fabricar uma composição - Google Patents

composição, e, método para fabricar uma composição

Info

Publication number
BRPI0815130A2
BRPI0815130A2 BRPI0815130A BRPI0815130A BRPI0815130A2 BR PI0815130 A2 BRPI0815130 A2 BR PI0815130A2 BR PI0815130 A BRPI0815130 A BR PI0815130A BR PI0815130 A BRPI0815130 A BR PI0815130A BR PI0815130 A2 BRPI0815130 A2 BR PI0815130A2
Authority
BR
Brazil
Prior art keywords
composition
making
Prior art date
Application number
BRPI0815130A
Other languages
English (en)
Inventor
Bucolo Claudio
Wayne Ward Keith
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of BRPI0815130A2 publication Critical patent/BRPI0815130A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
BRPI0815130A 2007-08-10 2008-08-05 composição, e, método para fabricar uma composição BRPI0815130A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95504407P 2007-08-10 2007-08-10
PCT/US2008/072201 WO2009023471A2 (en) 2007-08-10 2008-08-05 Compositions comprising a dissociated glucocorticoid receptor agonist for treating or controlling anterior-segment inflammation

Publications (1)

Publication Number Publication Date
BRPI0815130A2 true BRPI0815130A2 (pt) 2017-05-09

Family

ID=40263555

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0815130A BRPI0815130A2 (pt) 2007-08-10 2008-08-05 composição, e, método para fabricar uma composição

Country Status (18)

Country Link
US (1) US20090042936A1 (pt)
EP (1) EP2190431B1 (pt)
JP (1) JP5209718B2 (pt)
KR (2) KR101298826B1 (pt)
CN (1) CN101969950A (pt)
AU (1) AU2008287142B2 (pt)
BR (1) BRPI0815130A2 (pt)
CA (1) CA2694227C (pt)
CY (1) CY1114480T1 (pt)
DK (1) DK2190431T3 (pt)
ES (1) ES2421405T3 (pt)
HR (1) HRP20130631T1 (pt)
MX (1) MX2010001370A (pt)
PL (1) PL2190431T3 (pt)
PT (1) PT2190431E (pt)
SI (1) SI2190431T1 (pt)
TW (1) TWI410252B (pt)
WO (1) WO2009023471A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110077270A1 (en) * 2009-04-21 2011-03-31 Pfeffer Bruce A Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
US10278810B2 (en) * 2010-04-29 2019-05-07 Ojo, Llc Injectable physiologically adaptive intraocular lenses (IOL's)
US20120316199A1 (en) * 2011-06-07 2012-12-13 Ward Keith W Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain
PL3517541T3 (pl) 2012-05-08 2020-12-28 Nicox Ophthalmics, Inc. Postać polimorficzna propionianu flutykazonu
JP7516394B2 (ja) 2019-01-22 2024-07-16 アクリベス ビオメディカル ゲーエムベーハー 皮膚創傷治癒不全を治療するための選択的グルココルチコイド受容体モジュレーター
WO2020215084A1 (en) * 2019-04-18 2020-10-22 Teeny Clean, Llc Device and method for stimulating the meibomian glands of the eyelid

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US6051576A (en) * 1994-01-28 2000-04-18 University Of Kentucky Research Foundation Means to achieve sustained release of synergistic drugs by conjugation
US5773019A (en) * 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US6242196B1 (en) * 1997-12-11 2001-06-05 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
WO2000000194A1 (en) * 1998-06-27 2000-01-06 Photogenesis, Inc. Ophthalmic uses of ppargamma agonists and ppargamma antagonists
AU6275999A (en) * 1998-09-30 2000-04-17 Alcon Laboratories, Inc. Antibiotic compositions for treatment of the eye, ear and nose
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
EP1467982B8 (en) * 2002-01-14 2007-04-11 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
JP4324480B2 (ja) * 2002-03-26 2009-09-02 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメティクス、その製法、医薬組成物、及び使用
EP1490317A1 (en) * 2002-03-26 2004-12-29 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US6897224B2 (en) * 2002-04-02 2005-05-24 Schering Ag Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
US7074806B2 (en) * 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2004005229A1 (en) * 2002-07-08 2004-01-15 Pfizer Products Inc. Modulators of the glucocorticoid receptor
EP1583745A1 (en) * 2003-01-03 2005-10-12 Boehringer Ingelheim Pharmaceuticals Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20040224992A1 (en) * 2003-02-27 2004-11-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
WO2004097410A1 (en) * 2003-04-30 2004-11-11 Pfizer Products Inc. Screening methods for cataractogenic risk
UY28526A1 (es) * 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) * 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
EP1730145A1 (en) * 2004-03-22 2006-12-13 Boehringer Ingelheim Pharmaceuticals Inc. Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
DE102004055633A1 (de) * 2004-11-12 2006-05-18 Schering Ag 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
US7417056B2 (en) * 2004-11-12 2008-08-26 Schering Ag 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents
PE20060776A1 (es) * 2004-12-27 2006-09-26 Boehringer Ingelheim Pharma Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas
US8017775B2 (en) * 2005-09-14 2011-09-13 Santen Pharmaceutical Co., Ltd. 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity
EP2051710B1 (en) * 2006-08-07 2011-11-02 Bausch & Lomb Incorporated Compositions and methods for treating, reducing, ameliorating, or alleviating posterior-segment ophthalmic diseases
CA2660151C (en) * 2006-08-07 2012-04-17 Bausch & Lomb Incorporated Compositions and methods for treating, controlling, reducing, or ameliorating infections and sequelae thereof
KR20090050091A (ko) * 2006-08-31 2009-05-19 보오슈 앤드 롬 인코포레이팃드 녹내장 또는 그의 진행을 치료 또는 예방하기 위한 조성물 및 방법
EP2151436B1 (en) * 2007-05-29 2013-04-24 Santen Pharmaceutical Co., Ltd Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity
WO2008154129A1 (en) * 2007-06-08 2008-12-18 Bausch & Lomb Incorporated Pharmaceutical compositions and method for treating, reducing, ameliorating, alleviating, or preventing dry eye

Also Published As

Publication number Publication date
DK2190431T3 (da) 2013-09-08
TW200911286A (en) 2009-03-16
CA2694227C (en) 2012-07-03
KR101298826B1 (ko) 2013-08-27
PT2190431E (pt) 2013-10-09
SI2190431T1 (sl) 2013-10-30
KR20100029851A (ko) 2010-03-17
HRP20130631T1 (hr) 2013-08-31
HK1141249A1 (en) 2010-11-05
MX2010001370A (es) 2010-03-01
CY1114480T1 (el) 2016-10-05
CN101969950A (zh) 2011-02-09
AU2008287142A1 (en) 2009-02-19
KR20120113802A (ko) 2012-10-15
TWI410252B (zh) 2013-10-01
WO2009023471A2 (en) 2009-02-19
EP2190431B1 (en) 2013-07-03
WO2009023471A3 (en) 2009-06-25
ES2421405T3 (es) 2013-09-02
PL2190431T3 (pl) 2013-11-29
AU2008287142B2 (en) 2012-02-02
JP2010535796A (ja) 2010-11-25
US20090042936A1 (en) 2009-02-12
EP2190431A2 (en) 2010-06-02
JP5209718B2 (ja) 2013-06-12
CA2694227A1 (en) 2009-02-19

Similar Documents

Publication Publication Date Title
BRPI0912384A2 (pt) composição, e, método para preparar uma composição
BRPI0817727A2 (pt) composição de graxa lubrificante, e, método para preparar uma composição de graxa
BRPI0908092A2 (pt) Edulcorante, método para preparar uma composição edulcorante, e, composição edulcorante
BRPI0812847A2 (pt) Uretano acrilado, composição, e, método para reticular pelo menos parcialmente a composição
BRPI0818430A2 (pt) Composição antiperspirante sólida e método para a produção da mesma
BR112012000623A2 (pt) composição de emulsão estabilizada, método, e, método para preparar uma composição de emulsão estabilizada
BRPI0809573A2 (pt) composição, e, método
BRPI0819127A2 (pt) Método para cimentar.
BRPI0815387A2 (pt) composição farmacêutica, método para fazer uma composição farmacêutica e método de tratar uma condição
BRPI0921718A2 (pt) composição, método para produzir uma composição, e, artigo moldado
BRPI0918170A2 (pt) método, e, composição endurecível
BRPI0811747A2 (pt) Métodos e composições para a produção de solventes
BRPI0810296A2 (pt) estrutura de corda e método para formar uma estrutura de corda
BRPI0813419A2 (pt) Composição anti-congelamento, e método para aumentar a estabilidade térmica de uma composição anti-congelamento
BR112012002608A2 (pt) composição lubrificante, e, método para melhorar o desempenho de uma composição lubrificante.
BRPI0910950A2 (pt) haste de perfuração, e, método para fabricar uma haste de perfuração
BRPI0813659A2 (pt) Composição anticongelamento, e, método para aumentar a estabilidade térmica de uma composição anticongelamento
BRPI1007561A2 (pt) método para revitalizar uma composição contendo betume, e, composição
BRPI0918642A2 (pt) coque e método para fabricação do mesmo.
BRPI0812647A2 (pt) "composição e método para produzir a composição"
BRPI0814167A2 (pt) Composição, e, método
BRPI0820644A2 (pt) método de preparação de uma composição, e, composição
BRPI0807220B1 (pt) composição, e, métodos para aumentar a força de compressão de uma composição e para aumentar a retenção de fragrância de uma composição
BRPI0720705B8 (pt) método para preparar uma composição de espumação, e, composição de espumação
BRPI0917345A2 (pt) composição, e, método para produzir uma composição estabilizada.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]